ACKNOWLEDGMENTS
AbbVie and the authors thank all the trial investigators and the patients who participated in this clinical trial. Dalia Majumdar, PhD, provided medical writing support. Xifeng Wang, PhD, Relja Popovic, PhD, and Rajesh Kamalakar, MS, provided statistical support; Rohini Sen, PhD, reviewed the data and interpreted patient‐reported outcomes. Angela T. Hadsell, MS, provided editorial support. All are employees of AbbVie. Venetoclax is being developed in a collaboration between AbbVie and Genentech. AbbVie and Genentech provided financial support for the study (NCT02966782) and participated in the design, study conduct, analysis, and interpretation of the data, as well as in the writing, review, and approval of this publication.